You are here: Home » Companies » News
Business Standard

Lupin gets USFDA nod to market hypertension treatment tablets

The product is a generic version of US WorldMeds LLC's Corgard tablets in the same strengths

Press Trust of India  |  New Delhi 

drugs, medicines, USFDA

Drug firm on Monday said it has received final approval from the US health regulator to market generic Nadolol tablets, used for treatment of hypertension, in the American market.

The company has received final approval to market its USP, 20 mg, 40 mg and 80 mg from the United States Food and Drug Administration (USFDA), said in a filing to


The product is a generic version of US WorldMeds LLC's Corgard tablets in the same strengths, it added.

As per IMS MAT June 2017 data, USP in the three strengths had annual sales of around USD 109.8 million in the US, said.

The tablets are indicated for management of patients with angina pectoris and for the treatment of hypertension, it added.

of on Monday closed at Rs 1,038.15 on BSE, down 0.40 per cent from previous close.

First Published: Mon, October 09 2017. 20:29 IST
RECOMMENDED FOR YOU